Frontiers | Revisiting Interferons for Prophylactic and Therapeutic Treatment Against SARS-CoV-2

Revisiting Interferons for Prophylactic and Therapeutic Treatment Against SARS-CoV-2

7,451
Total downloads
25k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 22 Nov 2021

Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis

Cheng Zhang
Yi-Gang Feng
Chiwing Tam
Ning Wang
Yibin Feng

Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis

doi 10.3389/fimmu.2021.733171

4,017 views
23 citations

REVIEW

Published on 26 Mar 2021

Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2

Diana Garcia-del-Barco
Daniela Risco-Acevedo
Jorge Berlanga-Acosta
Frank Daniel Martos-Benítez
Gerardo Guillén-Nieto

Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2

doi 10.3389/fimmu.2021.655528

6,387 views
21 citations

ORIGINAL RESEARCH

Published on 09 Mar 2021

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

Marco Contoli
Alberto Papi
Luca Tomassetti
Paola Rizzo
Francesco Vieceli Dalla Sega
Francesca Fortini
Francesca Torsani
Luca Morandi
Luca Ronzoni
7 more
Gianluca Campo

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

doi 10.3389/fimmu.2021.648004

10,078 views
73 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Cytokines and Soluble Mediators in Immunity

Impact

25kTopic views
17kArticle views
7,451Article downloads